Characterization of the precursor of prostate-specific antigen - Activation by trypsin and by human glandular kallikrein

被引:190
作者
Takayama, TK [1 ]
Fujikawa, K [1 ]
Davie, EW [1 ]
机构
[1] UNIV WASHINGTON,DEPT UROL,SEATTLE,WA 98195
关键词
D O I
10.1074/jbc.272.34.21582
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The precursor or zymogen form of prostate specific antigen (pro-PSA) is composed of 244 amino acid residues including an amino-terminal propiece of 7 amino acids. Recombinant pro-PSA was expressed in Escherichia coli, isolated from inclusion bodies, refolded, and purified. The zymogen was readily activated by trypsin at a weight Patio of 50:1 to generate PSA, a serine protease that cleaves the chromogenic chymotrypsin substrate 3-carbomethoxypropionyl-L-arginyl-L-prolyl-L-tyrosine-p-nitroaniline-HCl (S-2586). In this activation, the amino-terminal propiece Ala-Pro-Leu-Ile-Leu-Ser-Arg was released by cleavage at the Arg-ne peptide bond. The recombinant pro-PSA was also activated by recombinant human glandular kallikrein, another prostate-specific serine protease, as well as by a partially purified protease(s) from seminal plasma, The recombinant PSA was inhibited by alpha 1-antichymotrypsin, forming an equimolar complex with a molecular mass of approximately 100 kDa, The recombinant PSA failed to activate single chain urokinase-type plasminogen activator, in contrast to the recombinant hK2, which readily activated single chain urokinase-type plasminogen activator, These results indicate that pro-PSA is converted to an active serine protease by minor proteolysis analogous to the activation of many of the proteases present in blood, pancreas, and other tissues. Furthermore, PSA is probably generated by a cascade system involving a series of precursor proteins. These proteins may interact in a stepwise manner similar to the generation of plasmin during fibrinolysis or thrombin during blood coagulation.
引用
收藏
页码:21582 / 21588
页数:7
相关论文
共 53 条
[1]   THE CHYMOTRYPSIN-LIKE ACTIVITY OF HUMAN PROSTATE-SPECIFIC ANTIGEN, GAMMA-SEMINOPROTEIN [J].
AKIYAMA, K ;
NAKAMURA, T ;
IWANAGA, S ;
HARA, M .
FEBS LETTERS, 1987, 225 (1-2) :168-172
[2]   MEASUREMENT OF PROSTATE-SPECIFIC ANTIGEN IN SERUM AS A SCREENING-TEST FOR PROSTATE-CANCER [J].
CATALONA, WJ ;
SMITH, DS ;
RATLIFF, TL ;
DODDS, KM ;
COPLEN, DE ;
YUAN, JJJ ;
PETROS, JA ;
ANDRIOLE, GL .
NEW ENGLAND JOURNAL OF MEDICINE, 1991, 324 (17) :1156-1161
[3]   REFOLDING RECOMBINANT PROTEINS - PROCESS STRATEGIES AND NOVEL APPROACHES [J].
CHAUDHURI, JB .
RECOMBINANT DNA TECHNOLOGY II, 1994, 721 :374-385
[4]   ENZYMATIC-ACTIVITY OF PROSTATE-SPECIFIC ANTIGEN AND ITS REACTIONS WITH EXTRACELLULAR SERINE PROTEINASE-INHIBITORS [J].
CHRISTENSSON, A ;
LAURELL, CB ;
LILJA, H .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1990, 194 (03) :755-763
[5]   THE HUMAN KALLIKREIN GENE FAMILY - A DIVERSITY OF EXPRESSION AND FUNCTION [J].
CLEMENTS, JA .
MOLECULAR AND CELLULAR ENDOCRINOLOGY, 1994, 99 (01) :C1-C6
[7]   PROSTATE-SPECIFIC ANTIGEN (PSA) IS AN INSULIN-LIKE GROWTH-FACTOR BINDING PROTEIN-3 PROTEASE FOUND IN SEMINAL PLASMA [J].
COHEN, P ;
GRAVES, HCB ;
PEEHL, DM ;
KAMAREI, M ;
GIUDICE, LC ;
ROSENFELD, RG .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1992, 75 (04) :1046-1053
[8]   Prostate specific antigen cleaves parathyroid hormone-related protein in the PTH-like domain: Inactivation of PTHrP-stimulated cAMP accumulation in mouse osteoblasts [J].
Cramer, SD ;
Chen, ZX ;
Peehl, DM .
JOURNAL OF UROLOGY, 1996, 156 (02) :526-531
[9]   PLASMINOGEN ACTIVATORS, TISSUE DEGRADATION, AND CANCER [J].
DANO, K ;
ANDREASEN, PA ;
GRONDAHLHANSEN, J ;
KRISTENSEN, P ;
NIELSEN, LS ;
SKRIVER, L .
ADVANCES IN CANCER RESEARCH, 1985, 44 :139-266
[10]   THE COAGULATION CASCADE - INITIATION, MAINTENANCE, AND REGULATION [J].
DAVIE, EW ;
FUJIKAWA, K ;
KISIEL, W .
BIOCHEMISTRY, 1991, 30 (43) :10363-10370